BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3974270)

  • 1. Cod-liver oil in the prevention of intimal hyperplasia in autogenous vein grafts used for arterial bypass.
    Landymore RW; Kinley CE; Cooper JH; MacAulay M; Sheridan B; Cameron C
    J Thorac Cardiovasc Surg; 1985 Mar; 89(3):351-7. PubMed ID: 3974270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cod-liver oil on intimal hyperplasia in vein grafts used for arterial bypass.
    Landymore RW; MacAulay MA; Cooper JH; Sheridan BL
    Can J Surg; 1986 Mar; 29(2):129-31. PubMed ID: 3006901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of intimal hyperplasia in canine autologous vein grafts with cod-liver oil and dipyridamole.
    Landymore RW; Cameron CA; Sheridan BL; MacAuley MA
    Can J Surg; 1986 Sep; 29(5):357-8. PubMed ID: 3019497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts.
    Landymore RW; MacAulay M; Sheridan B; Cameron C
    Ann Thorac Surg; 1986 Jan; 41(1):54-7. PubMed ID: 3942432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose marine oils on intimal hyperplasia in autologous vein grafts.
    Landymore RW; Manku MS; Tan M; MacAulay MA; Sheridan B
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 1):788-91. PubMed ID: 2554068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts.
    Landymore RW; Karmazyn M; MacAulay MA; Sheridan B; Cameron CA
    Can J Cardiol; 1988; 4(1):56-9. PubMed ID: 3359354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intimal hyperplasia in autogenous vein grafts used for arterial bypass: a canine model.
    Landymore RW; Kinley CE; Cameron CA
    Cardiovasc Res; 1985 Sep; 19(9):589-92. PubMed ID: 3876153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
    Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
    J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin on intimal hyperplasia and cholesterol uptake in experimental bypass grafts.
    Landymore RW; MacAulay MA; Fris J
    Can J Cardiol; 1991 Mar; 7(2):87-90. PubMed ID: 2049688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil.
    Sarris GE; Fann JI; Sokoloff MH; Smith DL; Loveday M; Kosek JC; Stephens RJ; Cooper AD; May K; Willis AL
    Circulation; 1989 Sep; 80(3 Pt 1):I109-23. PubMed ID: 2766520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
    Maekawa T; Komori K; Morisaki K; Itoh T
    J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversibility of canine vein-graft arterialization.
    Fann JI; Sokoloff MH; Sarris GE; Yun KL; Kosek JC; Miller DC
    Circulation; 1990 Nov; 82(5 Suppl):IV9-18. PubMed ID: 2225440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
    Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts].
    Li Q; Zhang K; Jiang X; Sun T; Wu L; Zhou C; Chen S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):354-8. PubMed ID: 18396721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perivenous support with autologous pericardium inhibits neointimal thickening in canine vein grafts].
    Yang HW; Wu RB; Guo HM; Zheng SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1006-8. PubMed ID: 16864099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin inhibits intimal hyperplasia in rabbit vein graft.
    Fujita H; Banno H; Yamanouchi D; Kobayashi M; Yamamoto K; Komori K
    J Surg Res; 2008 Aug; 148(2):238-43. PubMed ID: 18395752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vein graft intimal thickening by eicosapentanoic acid: reduced thromboxane production without change in lipoprotein levels or low-density lipoprotein receptor density.
    Cahill PD; Sarris GE; Cooper AD; Wood PD; Kosek JC; Mitchell RS; Miller DC
    J Vasc Surg; 1988 Jan; 7(1):108-18. PubMed ID: 3336117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.